A first-in-human trial investigating TG-6002 in glioblastoma patients

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 24 Mar 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

20 Mar 2017 According to a Transgene media release, this trial is expected to start in 2Q 2017. INCA (French national cancer institute) will support this trial.
05 Oct 2016 According to a Transgene media release, this trial will be conducted at Assistance Publique-Hopitaux de Paris (AP-HP) with Pr. Delattre as principal investigator.
05 Sep 2016 According to a Transgene media release, this trial is expected to start in first half of 2017

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com